Document is current
Any future updates will be listed below
-
Authors
Varkila, Meri R. J. https://orcid.org/0000-0002-2831-0292
Verboom, Diana M.
Derde, Lennie P. G.
van der Poll, Tom
Bonten, Marc J. M.
Cremer, Olaf L.
,
de Beer, Friso M.
Bos, Lieuwe D. J.
Glas, Gerie J.
Hoogendijk, Arie J.
van Hooijdonk, Roosmarijn T. M.
Horn, Janneke
Huson, Mischa A.
Juffermans, Nicole P.
Schouten, Laura R. A.
Scicluna, Brendon
Schultz, Marcus J.
Straat, Marleen
van Vught, Lonneke A.
Wieske, Luuk
Wiewel, Maryse A.
Witteveen, Esther
Bonten, Marc J. M.
Cremer, Olaf L.
Frencken, Jos F.
van de Groep, Kirsten
Klouwenberg, Peter M. C. Klein
Koster-Brouwer, Maria E.
Ong, David S. Y.
Varkila, Meri R. J.
Verboom, Diana M.
- License Information
-
More Information
Article History
Received: 7 December 2023
Accepted: 18 March 2024
First Online: 27 March 2024
Declarations
:
: This study was performed using the Molecular Diagnosis and Risk Stratification of Sepsis (MARS) biorepository, for which consecutive patients had been prospectively enrolled in the mixed ICUs of two university medical centers in The Netherlands (AMC Amsterdam 2011–2013 and UMC Utrecht 2011–2018). The Medical Ethics Committees of the participating study centers (Medical Research Ethics Committee Utrecht and Medical Research Ethics Committee AMC Amsterdam) approved an opt-out consent method for the MARS biorepository (IRB no. 10-1056C). Participants were hereby notified of the study in writing by a brochure provided at ICU admission with attached an opt-out card that could be completed by the patient or by his or her legal representative in case of unwillingness to participate.
: Not applicable.
: The authors declare that they have no competing interests.
